Drug profile

The FDA adverse-event record for Bovine Parainfluenza Virus 3 (Ts), Rlb103 (Nl-Bk-6);Bovine Respiratory Syncytial

22 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Bovine Parainfluenza Virus 3 (Ts), Rlb103 (Nl-Bk-6);Bovine Respiratory Syncytial. See the species affected, top reactions, and outcomes below.

22
adverse-event reports
100.0%
death-coded share
Cattle
most-reported species
22
Death - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
22
Total Reports
22
Deaths Reported
100.0%
Death Rate

Active Ingredients

Bovine Parainfluenza Virus 3 (Ts), Rlb103 (Nl-Bk-6);Bovine Respiratory Syncytial

Administration Routes

NasalSubcutaneous

Species Affected

Cattle 22

Most Affected Breeds

Mixed (Cattle) 20
Cattle (other) 1
Holstein-Friesian also known as Holstein 1

Most Reported Reactions

Death 22
Lack of efficacy - NOS 16
Necropsy performed 7
Lack of efficacy (bacteria) - NOS 3
Lack of efficacy (mycoplasma) - NOS 1
Extra dose(s) administered 1
Lack of efficacy (virus) - NOS 1
Anaphylactic-type reaction 1
Death by euthanasia 1
Injection site seroma 1
Injection site abscess 1
Third eyelid protrusion 1

Outcome Breakdown

Died
22 (48.9%)
Outcome Unknown
11 (24.4%)
Ongoing
8 (17.8%)
Euthanized
2 (4.4%)
Recovered with Sequela
1 (2.2%)
Recovered/Normal
1 (2.2%)

Bovine Parainfluenza Virus 3 (Ts), Rlb103 (Nl-Bk-6);Bovine Respiratory Syncytial Adverse Event Insights

22 reports name Bovine Parainfluenza Virus 3 (Ts), Rlb103 (Nl-Bk-6);Bovine Respiratory Syncytial; 22 recorded a death outcome (100.0% of reported events, not a population-level mortality rate). Active ingredient: Bovine Parainfluenza Virus 3 (Ts), Rlb103 (Nl-Bk-6);Bovine Respiratory Syncytial. Administration routes: Nasal, Subcutaneous.

By species: Cattle (22 reports). By breed: Mixed (Cattle) (20), Cattle (other) (1), Holstein-Friesian also known as Holstein (1).

Leading clinical signs: Death (22), Lack of efficacy - NOS (16), Necropsy performed (7), Lack of efficacy (bacteria) - NOS (3). Outcome, 45 coded reports: Died leads at 48.9%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.